The effect of antiaggregating drugs on the patency of grafts in the arterial system.
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage*; D001012:Aorta, Abdominal / Q000601:surgery; D001241:Aspirin / Q000008:administration & dosage; D001807:Blood Vessel Prosthesis; D004176:Dipyridamole / Q000008:administration & dosage; D004285:Dogs; D004873:Ergolines / Q000008:administration & dosage; D005260:Female; D007083:Iliac Artery / Q000601:surgery; D007601:Jugular Veins / Q000637:transplantation; D008297:Male; D010208:Papaverine / Q000008:administration & dosage; D011292:Premedication; D011300:Preoperative Care; D013927:Thrombosis / Q000517:prevention & control*; D014182:Transplantation, Autologous
D000925:Anticoagulants; D004873:Ergolines; C100272:ergotoxine; D004176:Dipyridamole; D010208:Papaverine; D001241:Aspirin